T. Rowe Price Associates’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $241M | Sell |
4,509,325
-307,766
| -6% | -$16.4M | 0.03% | 397 |
|
|
2025
Q1 | $195M | Buy |
4,817,091
+495,119
| +11% | +$20M | 0.02% | 424 |
|
|
2024
Q4 | $120M | Buy |
4,321,972
+513,613
| +13% | +$14.3M | 0.01% | 534 |
|
|
2024
Q3 | $109M | Sell |
3,808,359
-337,992
| -8% | -$9.7M | 0.01% | 548 |
|
|
2024
Q2 | $97.3M | Buy |
4,146,351
+85,872
| +2% | +$2.01M | 0.01% | 548 |
|
|
2024
Q1 | $103M | Buy |
4,060,479
+384,555
| +10% | +$9.71M | 0.01% | 546 |
|
|
2023
Q4 | $85.8M | Sell |
3,675,924
-134,270
| -4% | -$3.14M | 0.01% | 575 |
|
|
2023
Q3 | $193M | Buy |
3,810,194
+520,551
| +16% | +$26.3M | 0.03% | 397 |
|
|
2023
Q2 | $154M | Buy |
3,289,643
+665,963
| +25% | +$31.1M | 0.02% | 436 |
|
|
2023
Q1 | $100M | Buy |
2,623,680
+222,643
| +9% | +$8.52M | 0.02% | 510 |
|
|
2022
Q4 | $132M | Buy |
2,401,037
+938,613
| +64% | +$51.4M | 0.02% | 449 |
|
|
2022
Q3 | $49.8M | Buy |
1,462,424
+1,007,122
| +221% | +$34.3M | 0.01% | 646 |
|
|
2022
Q2 | $4.3M | Sell |
455,302
-62
| -0% | -$586 | ﹤0.01% | 1438 |
|
|
2022
Q1 | $6.46M | Sell |
455,364
-704,166
| -61% | -$9.99M | ﹤0.01% | 1422 |
|
|
2021
Q4 | $24.5M | Buy |
1,159,530
+7,931
| +0.7% | +$168K | ﹤0.01% | 1235 |
|
|
2021
Q3 | $25.7M | Sell |
1,151,599
-2,604
| -0.2% | -$58.2K | ﹤0.01% | 1230 |
|
|
2021
Q2 | $28.6M | Buy |
1,154,203
+261,057
| +29% | +$6.48M | ﹤0.01% | 1208 |
|
|
2021
Q1 | $25.9M | Buy |
893,146
+235,691
| +36% | +$6.84M | ﹤0.01% | 1208 |
|
|
2020
Q4 | $17M | Buy |
657,455
+154,974
| +31% | +$4M | ﹤0.01% | 1254 |
|
|
2020
Q3 | $15.5M | Buy |
502,481
+355,949
| +243% | +$11M | ﹤0.01% | 1207 |
|
|
2020
Q2 | $3.65M | Sell |
146,532
-92,946
| -39% | -$2.32M | ﹤0.01% | 1422 |
|
|
2020
Q1 | $5.08M | Buy |
239,478
+13,079
| +6% | +$277K | ﹤0.01% | 1340 |
|
|
2019
Q4 | $5.03M | Buy |
226,399
+22,486
| +11% | +$499K | ﹤0.01% | 1393 |
|
|
2019
Q3 | $4.64M | Buy |
203,913
+2,413
| +1% | +$54.9K | ﹤0.01% | 1387 |
|
|
2019
Q2 | $3.86M | Buy |
+201,500
| New | +$3.86M | ﹤0.01% | 1428 |
|